Patents by Inventor Peter H. Stahl

Peter H. Stahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-TRKB ANTIBODIES
    Publication number: 20240101689
    Abstract: The present invention relates to novel agonistic anti-TrkB antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: November 28, 2023
    Publication date: March 28, 2024
    Inventors: Rolf HERRMANN, Remko Alexander BAKKER, Sebastian BANDHOLTZ, Peter Michael BENZ, Michael DZIEGELEWSKI, Lore Katharina FLORIN, Cynthia Hess KENNY, Sarah Kathleen LOW, Holger ROSENBROCK, Sanjaya SINGH, Heiko Friedrich STAHL, Sathyadevi VENKATARAMANI, Vladimir H. VOYNOV, Haiguang XIAO
  • Topical formulations
    Patent number: 5139786
    Abstract: The invention relates to topically administrable pharmaceutical preparations containing pharmaceutically acceptable methanediphosphonic acid derivatives of formula ##STR1## and their salts, wherein R.sub.1 and R.sub.2 are hydrogen or C.sub.1 -C.sub.3 alkyl.
    Type: Grant
    Filed: December 20, 1991
    Date of Patent: August 18, 1992
    Assignees: Ciba-Geigy Corporation, Henkel Kommanditgesellschaft auf Aktien
    Inventors: Pier G. Ferrini, Carlo Voellmy, Peter H. Stahl, Jonathan Green
  • Topically administrable pharmaceutical preparations
    Patent number: 5133972
    Abstract: The invention relates to topically adminstrable pharmaceutical preparations containing pharmaceutically acceptable methanediphosphonic acid derivatives of formula ##STR1## and their salts, wherein each of R.sub.1 and R.sub.2 is halogen, or wherein R.sub.1 is hydrogen and R.sub.2 is Ar--S-- or Het.sub.1 --NH--, in which Ar is unsubstituted or substituted phenyl and Het.sub.1 is unsubstituted or substituted, monocyclic, 5- or 6-membered monoaza-, diaza- or thiaza-aryl that is bonded via a ring carbon atom, or wherein R.sub.1 is hydrogen or hydroxy and R.sub.2 is --A--R.sub.3, in which A is alkylene and, on the one hand, R.sub.3 is Het.sub.2, which is Het.sub.1 bonded via a ring carbon or ring nitrogen atom, or, on the other hand, R.sub.3 is hydrogen, or amino that is unsubsituted or mono- or di-substituted by identical or different substituents selected from alkyl, cycloalkyl, Ar-alkyl, Ar-O-alkyl, Ar-S-alkyl and Het.sub.
    Type: Grant
    Filed: June 29, 1990
    Date of Patent: July 28, 1992
    Assignee: Ciba-Geigy Corporation
    Inventors: Pier G. Ferrini, Carlo Voellmy, Peter H. Stahl, Jonathan Green
  • Crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
    Patent number: 4711880
    Abstract: The invention relates to a novel crystal modification, containing water of crystallization, of disodium 3-amino-1-hydroxypropane-1,1-diphosphonate of the formula ##STR1## and to a process for the manufacture thereof. This modification is suitable for the oral treatment of disorders of the calcium and phosphate metabolism and associated diseases in warm-blooded animals.
    Type: Grant
    Filed: September 8, 1986
    Date of Patent: December 8, 1987
    Assignees: Ciba-Geigy Corporation, Henkel Kommanditgesellschaft auf Aktien
    Inventors: Peter H. Stahl, Beat Schmitz
  • Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
    Patent number: 4639338
    Abstract: The invention relates to a novel crystal modification, containing water of crystallization, of disodium 3-amino-1-hydroxypropane-1,1-diphosphonate of the formula ##STR1## and to a process for the manufacture thereof. This modification is suitable for the oral treatment of disorders of the calcium and phosphate metabolism and associated diseases in warm-blooded animals.
    Type: Grant
    Filed: July 29, 1985
    Date of Patent: January 27, 1987
    Assignees: Ciba-Geigy Corporation, Henkel Kommanditgesellschaft auf Aktien
    Inventors: Peter H. Stahl, Beat Schmitz